| Oct 19, 2009
Rushed into production? Not really.
Full of substances that do harm? Hardly, and especially not compared with the dangers of the H1N1 flu virus.
That is the retort of researchers, scientists, federal health authorities and others familiar...
| Feb 16, 2009
It's one instance where quitting isn't the easy way out.
FOR THE RECORD:
Zyban: In Monday's Health section, an article on quitting smoking said that the smoking-cessation medication Zyban might act by blocking the brain chemicals...
| Feb 18, 2011
| 3:13 PM
A cardiologist, endocrinologist, psychiatrist, nurse practitioner and allergist. These five medical professionals in Burbank and Glendale may have different specialties, but they have one source of income in common — drug companies.
Since 2009, 33...
| Aug 19, 2010
The safety of most diabetes drugs are time-tested — insulin was discovered in the early 1920s, and two of the other most commonly prescribed, metformin and sulfonylurea, have been around since the 1950s.
Avandia is different. The drug landed with a...
| Aug 20, 2010
A 58-year-old psychiatrist involved in two clinical trials evaluating the drug Paxil's safety and effectiveness in children and adolescents has pleaded guilty to 15 federal counts of failing to prepare and maintain records, with intent to defraud and...
| Sep 30, 2010
| 6:47 AM
(Reuters) - GlaxoSmithKline's herpes vaccine failed to protect women against the virus in a trial, the U.S. National Institutes of Health said Thursday, and the company said it was stopping development of the product.
The test of 8,000 women in the U.S....
| Oct 18, 2010
| 9:13 PM
Follow drug company money in Illinois, and it leads to the psychiatry department at Rush University Medical Center, a prominent headache clinic on the North Side of Chicago, a busy suburban urology practice and a psychiatric hospital accused of...
| Oct 28, 2010
| 7:23 PM
Last week, after the launch of a new database detailing doctors' financial ties with drug companies, Dr. Daniel Carlat sat at his computer and began searching for information about colleagues.
He found several doctors who had potentially compromising...
| Jan 29, 2009
I'm grateful for the opportunity to be here today and present my closing argument and my chance to talk to you and talk to the people of Illinois and talk to anybody else who is listening.
In the last couple of days I've had a chance to be able to go out...
| Jul 13, 2010
| 8:26 AM
GlaxoSmithKline agreed to pay about $460 million to resolve a majority of lawsuits alleging the company's Avandia diabetes drug can cause heart attacks and strokes, people familiar with the accords said.
Glaxo, the U.K.'s biggest drugmaker, agreed to...
| Jun 30, 2010
| 2:11 PM
The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on.
So, when is a drug too risky to stay on the market?